000 04009cam a2200385Ma 4500
001 94577
003 ES-MaUEC
005 20230102112619.0
006 m o d
007 cr cnu---unuuu
008 160917s2016 sz obf 000 0 eng d
020 _a3319267825
_q(electronic bk.)
020 _a9783319267821
_q(electronic bk.)
020 _z3319267809
020 _z9783319267807
035 _a(OCoLC)958573375
_z(OCoLC)958449349
_z(OCoLC)958455449
_z(OCoLC)958830582
_z(OCoLC)962789716
040 _aEBLCP
_cEBLCP
_dN$T
_dIDEBK
_dN$T
_dGW5XE
_dYDX
_dOCLCQ
_dOCLCF
_dUAB
_dIOG
_dESU
_dJBG
_dIAD
_dICW
_dICN
_dOTZ
_dOCLCQ
_dU3W
_dMERUC
_dES-MaUEC
_bspa
050 4 _aRC669
_b2017 EB
245 0 0 _aHandbook of Cardiovascular Disease Management in Rheumatoid Arthritis
_ceditor, Anne Grete Semb.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2016
300 _a1 recurso en línea (122 páginas)
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
504 _aIncluye referencias bibliográficas
505 0 _aEditor and author biographies; Abbreviations; Preface; 1 Overview of rheumatoid arthritis and mortality in relation to cardiovascular disease; Global burden of rheumatoid arthritis: trends inincidence, prevalence, and mortality; Epidemiology and outcomes of cardiovascular disease in rheumatoid arthritis; References; 2 Non-atherosclerotic cardiac manifestations of rheumatoid arthritis; Pericardial diseases; Myocardial diseases; Cardiac amyloidosis; Non-atherosclerotic coronary artery disease; Arrhythmias; Valvular heart disease; References.
505 8 _a3 Risk factors for cardiovascular disease in rheumatoid arthritisTraditional cardiovascular risk factors in patients with rheumatoid arthritis; The impact of rheumatoid arthritis disease activity and severity on cardiovascular comorbidity; The role of inflammation in the development of cardiovascular disease manifestations of rheumatoid arthritis; References; 4 Cardiovascular disease risk evaluation; Screening for and diagnostics of cardiovascular disease in rheumatoid arthritis; Cardiovascular disease risk calculators; Cardiovascular disease prevention; References.
505 8 _a5 Pharmacological management of cardiovascular disease in patients with rheumatoid arthritisIntroduction; Current treatment recommendations; Pharmacological cardio-protective treatment in patients with rheumatoid arthritis; The role of anti-rheumatic medications; References; 6 Non-pharmacological interventions for cardiovascular complications in patients with rheumatoid arthritis; Introduction; Smoking; Weight control and body composition; Physical exercise; References; 7 Conclusions; Exploring therapeutic targets; New medications to treat both indications.
520 3 _aThis book is a practical and up-to-date review that discusses the impact of traditional cardiovascular risk factors in patients with rheumatoid arthritis, the effect of rheumatoid arthritis disease activity and severity on cardiovascular comorbidity, and the influence of rheumatoid arthritis drug therapy on cardiovascular risk. This title also explores cardiovascular disease as a manifestation of rheumatoid arthritis and highlights the available methods for screening and diagnosing these conditions. Current and emerging therapies to aid clinicians in the daily management of their patients are also featured in this title. Busy healthcare professionals who are looking for a collaborative approach to these conditions will benefit from this comprehensive overview.
650 7 _aAparato circulatorio
_xEnfermedades
_2embne
_0(OCoLC)fst00847213
_0
_9169062
700 1 _aSemb, Anne Grete.
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-26782-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c94577
_d94577
_x1